Jens Bjørn Jensen

Title: Jens Bjørn Jensen: Innovator in Pharmaceutical Development

Introduction

Jens Bjørn Jensen is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as protein tyrosine kinase inhibitors. His work has the potential to impact various therapeutic areas.

Latest Patents

Jensen holds a patent for "Sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof." This invention relates to compounds of general Formula (I), wherein R, R, R, R, R, m, and n are defined. These compounds, along with their pharmaceutically acceptable salts, prodrugs, hydrates, or solvates, are intended for use in therapy. They can be utilized alone or in combination with other pharmaceutically active compounds to prevent, treat, or ameliorate diseases such as psoriasis, atopic dermatitis, lupus, multiple sclerosis, and various cancers, among others.

Career Highlights

Jensen is currently associated with Leo Pharma A/S, a company renowned for its focus on dermatology and critical care. His work at Leo Pharma has allowed him to explore innovative solutions in the pharmaceutical industry, contributing to advancements in treatment options for patients.

Collaborations

Throughout his career, Jensen has collaborated with talented individuals such as Søren Christian Schou and Daniel Rodriguez Greve. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Jens Bjørn Jensen is a distinguished inventor whose work in pharmaceutical development has the potential to transform treatment methodologies for various diseases. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.